Neurocrine Biosciences schedules Q3 2026 earnings call for November 2

Neurocrine Biosciences announced its third quarter 2026 financial results conference call and webcast will be held on November 2, 2026, at 1:30 p.m. Pacific Time. The company will release its Q3 2026 earnings report at 1:00 p.m. PT the same day. Investors can access the webcast on Neurocrine's website, with a replay available for about a month. This event provides insights into the company's financial health and progress in developing treatments for neurological and other disorders.

Neurocrine Biosciences (NBIX) trades at USD 141.56 on Pluang as of Oct 13, 2026 03:11 WIB, down 0.62% in the past day. The stock shows a market cap of $14.47 billion and a 52-week range between $123.10 and $185.50. Ahead of the Q3 2026 earnings call scheduled for November 2, the Pluang platform records a full sell order activity, indicating cautious sentiment among investors.